MedPath

Factors and Prognosis of Obstructive Pyelonephritis Patients

Recruiting
Conditions
Pyelonephritis
Prognostic
Registration Number
NCT06299215
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

Acute obstructive pyelonephritis is a condition with a high risk of complications and may require admission to the intensive care unit.

Most of the available data on this condition comes from small, retrospective, single-centre series.

To date, no large-scale study has examined the factors associated with the prognosis of patients admitted to intensive care for acute obstructive pyelonephritis.

The aim of this study is to describe the population and prognosis of patients admitted to the intensive care unit for the management of acute obstructive pyelonephritis, and to identify factors associated with a poor prognosis in these patients.

Detailed Description

The retrospective and multicenter study consists of a retrospective and pseudonymous collection of data from medical reports of patients treated, over the period 2015-2022, in each intensive care unit agreeing to participate, .

Investigators from each participating center will be responsible for screening on all hospitalized patients over the period 2015-2022. Patients who have been hospitalized for the management of acute obstructive pyelonephritis will be included, in the absence of non-inclusion criteria.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Patients over 18 years of age
  • Hospitalized in intensive care for management of acute obstructive pyelonephritis
  • Patients affiliated to a Social Security System
Read More
Exclusion Criteria
  • Pregnancy
  • Opposition to data use
  • Persons under legal protection (curatorship, guardianship), legal safeguards
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint will be a combined endpoint of death, and/or stage 3 AKI ( KDIGO classification), and/or non-recovery of renal function.up to 30 days after admission to intensive care
Secondary Outcome Measures
NameTimeMethod
the incidence of acute renal failure defined by KDIGO 2 and 3up to 30 days after admission to intensive care
the incidence of Renal replacement therapyup to 30 days after admission to intensive care
The number of days alive without Renal replacement therapyup to 30 days after admission to intensive care
the incidence of non-recovery of renal fuctionup to 30 days after admission to intensive care
The number of days alive without antibioticsup to 30 days after admission to intensive care
Deathup to 30 days after admission to intensive care
Stage 3 Acute kidney injury (KDIGO classification)up to 30 days after admission to intensive care
failure to recover renal functionup to 30 days after admission to intensive care .

defined as creatinine levels greater than 150% of baseline value

the incidence of acute renal failure defined by KDIGO 1up to 30 days after admission to intensive care
The number of days alive without catecholaminesup to 30 days after admission to intensive care
The number of days alive withoutup to 30 days after admission to intensive care
Death rateup to 30 days after admission to intensive care

Trial Locations

Locations (1)

Hospital Saint Louis

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath